Literature DB >> 17587179

Genetics of septo-optic dysplasia.

Daniel Kelberman1, Mehul Tulsidas Dattani.   

Abstract

Septo-optic dysplasia (SOD) is a highly heterogeneous condition comprising a variable phenotype of optic nerve hypoplasia, midline forebrain abnormalities and pituitary hypoplasia with consequent endocrine deficits. The majority of cases are sporadic and several aetiologies including drug and alcohol abuse have been suggested to account for the pathogenesis of the condition. However, a number of familial cases have been described and the identification of mutations in the key developmental gene HESX1 in patients with SOD and associated phenotypes suggests that a genetic causation is likely in the more common sporadic cases of the condition. More recently, we have implicated duplications of SOX3 and mutations of both SOX2 and SOX3 in the aetiology of variants of SOD. As with other developmental disorders such as holoprosencephaly, the precise aetiology is most likely multifactorial involving contributions from environmental factors in addition to an important role for crucial developmental genes. This potentially complex interaction between genetics and the environment is borne out by the variability of the penetrance and phenotypes in patients with genetic SOD, but at present, the understanding of these interactions is rudimentary. Further study of these critical factors may shed light on the aetiology of this complex disorder.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17587179     DOI: 10.1007/s11102-007-0055-5

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  116 in total

Review 1.  Signaling mechanisms in pituitary morphogenesis and cell fate determination.

Authors:  J S Dasen; M G Rosenfeld
Journal:  Curr Opin Cell Biol       Date:  1999-12       Impact factor: 8.382

2.  Septo-optic dysplasia: developmental or acquired abnormality? A case report.

Authors:  B Zaias; D Becker
Journal:  Trans Am Neurol Assoc       Date:  1978

3.  Heterozygous HESX1 mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasia.

Authors:  P Q Thomas; M T Dattani; J M Brickman; D McNay; G Warne; M Zacharin; F Cameron; J Hurst; K Woods; D Dunger; R Stanhope; S Forrest; I C Robinson; R S Beddington
Journal:  Hum Mol Genet       Date:  2001-01-01       Impact factor: 6.150

4.  Transcription factor SOX3 is involved in X-linked mental retardation with growth hormone deficiency.

Authors:  Frédéric Laumonnier; Nathalie Ronce; Ben C J Hamel; Paul Thomas; James Lespinasse; Martine Raynaud; Christine Paringaux; Hans Van Bokhoven; Vera Kalscheuer; Jean-Pierre Fryns; Jamel Chelly; Claude Moraine; Sylvain Briault
Journal:  Am J Hum Genet       Date:  2002-11-08       Impact factor: 11.025

5.  Integrated FGF and BMP signaling controls the progression of progenitor cell differentiation and the emergence of pattern in the embryonic anterior pituitary.

Authors:  J Ericson; S Norlin; T M Jessell; T Edlund
Journal:  Development       Date:  1998-03       Impact factor: 6.868

6.  Optic nerve hypoplasia. Clinical significance of associated central nervous system abnormalities on magnetic resonance imaging.

Authors:  M C Brodsky; C M Glasier
Journal:  Arch Ophthalmol       Date:  1993-01

7.  Sox2 is required for sensory organ development in the mammalian inner ear.

Authors:  Amy E Kiernan; Anna L Pelling; Keith K H Leung; Anna S P Tang; Donald M Bell; Charles Tease; Robin Lovell-Badge; Karen P Steel; Kathryn S E Cheah
Journal:  Nature       Date:  2005-04-21       Impact factor: 49.962

8.  Neuroradiological features of patients with optic nerve hypoplasia.

Authors:  S M Zeki; A S Hollman; G N Dutton
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1992 Mar-Apr       Impact factor: 1.402

9.  Pax-6, a murine paired box gene, is expressed in the developing CNS.

Authors:  C Walther; P Gruss
Journal:  Development       Date:  1991-12       Impact factor: 6.868

10.  Comparative expression of the mouse Sox1, Sox2 and Sox3 genes from pre-gastrulation to early somite stages.

Authors:  H B Wood; V Episkopou
Journal:  Mech Dev       Date:  1999-08       Impact factor: 1.882

View more
  25 in total

Review 1.  Prenatal determinants of optic nerve hypoplasia: review of suggested correlates and future focus.

Authors:  Pamela Garcia-Filion; Mark Borchert
Journal:  Surv Ophthalmol       Date:  2013 Nov-Dec       Impact factor: 6.048

Review 2.  Septo-optic dysplasia.

Authors:  Emma A Webb; Mehul T Dattani
Journal:  Eur J Hum Genet       Date:  2009-07-22       Impact factor: 4.246

Review 3.  SOXopathies: Growing Family of Developmental Disorders Due to SOX Mutations.

Authors:  Marco Angelozzi; Véronique Lefebvre
Journal:  Trends Genet       Date:  2019-07-06       Impact factor: 11.639

4.  Magnetic resonance diffusion tensor imaging (MRDTI) and tractography in children with septo-optic dysplasia.

Authors:  Michael B Salmela; Keith A Cauley; Joshua P Nickerson; Chris J Koski; Christopher G Filippi
Journal:  Pediatr Radiol       Date:  2009-12-09

5.  Candidate gene sequencing of LHX2, HESX1, and SOX2 in a large schizencephaly cohort.

Authors:  Cecilia Mellado; Annapurna Poduri; Danielle Gleason; Princess C Elhosary; Brenda J Barry; Jennifer N Partlow; Bernard S Chang; Gary M Shaw; A James Barkovich; Christopher A Walsh
Journal:  Am J Med Genet A       Date:  2010-11       Impact factor: 2.802

6.  Septo-optic dysplasia: fitting the pieces together.

Authors:  Nélia Ferraria; Sofia Castro; Daniela Amaral; Lurdes Lopes
Journal:  BMJ Case Rep       Date:  2013-05-24

Review 7.  Genetics of Combined Pituitary Hormone Deficiency: Roadmap into the Genome Era.

Authors:  Qing Fang; Akima S George; Michelle L Brinkmeier; Amanda H Mortensen; Peter Gergics; Leonard Y M Cheung; Alexandre Z Daly; Adnan Ajmal; María Ines Pérez Millán; A Bilge Ozel; Jacob O Kitzman; Ryan E Mills; Jun Z Li; Sally A Camper
Journal:  Endocr Rev       Date:  2016-11-09       Impact factor: 19.871

Review 8.  Combined pituitary hormone deficiency: current and future status.

Authors:  F Castinetti; R Reynaud; M-H Quentien; N Jullien; E Marquant; C Rochette; J-P Herman; A Saveanu; A Barlier; A Enjalbert; T Brue
Journal:  J Endocrinol Invest       Date:  2014-09-09       Impact factor: 4.256

9.  Novel FGF8 mutations associated with recessive holoprosencephaly, craniofacial defects, and hypothalamo-pituitary dysfunction.

Authors:  Mark J McCabe; Carles Gaston-Massuet; Vaitsa Tziaferi; Louise C Gregory; Kyriaki S Alatzoglou; Massimo Signore; Eduardo Puelles; Dianne Gerrelli; I Sadaf Farooqi; Jamal Raza; Joanna Walker; Scott I Kavanaugh; Pei-San Tsai; Nelly Pitteloud; Juan-Pedro Martinez-Barbera; Mehul T Dattani
Journal:  J Clin Endocrinol Metab       Date:  2011-08-10       Impact factor: 5.958

10.  AN UNEXPECTED COMBINATION OF PROLACTINOMA AND SEPTO-OPTIC DYSPLASIA.

Authors:  Marie-Noel Rahhal; Laure Sayyed Kassem
Journal:  AACE Clin Case Rep       Date:  2019-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.